Jupiter Neurosciences reported asset growth of -6.29% for the quarter ended Jun 2026. These growth metrics cover 11 quarters of results from Dec 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Growth MetricsGrowth | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth Ratios | |||||||||||
| Total Debt (QoQ) | -93.14% | 0.00% | 0.00% | 0.00% | 3,518.11% | -8.94% | -68.32% | ||||
| Total Debt Growth (1y) | -92.67% | -93.14% | 3,518.11% | 3,194.64% | 943.81% | ||||||
| Share-based Compensation (QoQ)Stock Comp. (QoQ) | -71.86% | 853.83% | -65.92% | 419.62% | -58.42% | -9.79% | 2.51% | 18.87% | 8.15% | -24.11% | |
| Share-based Compensation Growth (1y)Stock Comp. Growth (1y) | 375.39% | 602.42% | -33.57% | 99.79% | -54.30% | 18.87% | 0.00% | ||||
| Revenue (QoQ) | 29.99% | ||||||||||
| Return on Sales [ROS] (QoQ)ROS (QoQ) | -0.08M | ||||||||||
| Return on Equity [ROE] (QoQ)ROE (QoQ) | -0.01M | -0.08M | |||||||||
| Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) | 0.02M | -0.02M | -0.07M | ||||||||
| Return on Assets [ROA] (QoQ)ROA (QoQ) | 0.00M | -0.01M | -0.01M | 0.00M | 0.00M | -0.01M | |||||
| Return on Assets [ROA] Growth (1y)ROA Growth (1y) | -0.01M | -0.01M | -0.01M | ||||||||
| Operating Margin (QoQ) | -0.08M | ||||||||||
| Operating Income (QoQ)Op. Inc (QoQ) | 62.86% | -6.54% | 2.39% | 11.40% | -195.48% | -5.46% | -47.26% | -1.42% | -22.28% | 30.11% | -39.73% |
| Operating Income Growth (1y)Op. Inc Growth (1y) | 65.78% | -172.26% | -169.50% | -306.56% | -365.42% | -92.60% | -27.63% | -21.11% | |||
| Net Margin (QoQ) | 0.17M | ||||||||||
| Net Income towards Common Stockholders (QoQ)Net Income (QoQ) | 75.78% | -47.59% | 149.38% | -288.75% | -158.47% | -0.08% | -47.36% | -1.56% | -12.54% | 19.92% | -10.30% |
| Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) | 66.69% | -255.56% | -141.11% | -819.51% | -287.13% | -68.56% | -34.87% | -0.95% | |||
| Net Income (QoQ) | 75.78% | -47.59% | 149.38% | -288.75% | -158.47% | -0.08% | -47.36% | -1.56% | -12.54% | 19.92% | -10.30% |
| Net Income Growth (1y) | 66.69% | -255.56% | -141.11% | -819.51% | -287.13% | -68.56% | -34.87% | -0.95% | |||
| Net Cash Flow (QoQ)NCF (QoQ) | 35.24% | 132.42% | -323.28% | 25,920.37% | -128.20% | 22.09% | -39.39% | -105.12% | 39.76% | 41.06% | |
| Net Cash Flow Growth (1y)NCF Growth (1y) | 12,205.40% | -5,171.71% | -12,767.82% | -7,808.28% | -162.82% | -34.20% | -1.53% | ||||
| Interest Coverage Ratio (QoQ)Interest Cover (QoQ) | 48.72% | 5.40% | -14.03% | 53.56% | -938.79% | -2,521.09% | -59.46% | 3.51% | 97.66% | 63.21% | -82.95% |
| Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y) | 74.31% | -420.40% | -14,319.05% | -20,063.47% | -41,792.24% | 5.82% | 98.68% | 98.48% | |||
| Income After Tax (QoQ) | 58.07% | 0.31% | 3.63% | 2.02% | -146.87% | -3.06% | -47.36% | -1.56% | -25.49% | 28.14% | -36.85% |
| Income After Tax Growth (1y) | 60.53% | -132.39% | -140.24% | -267.34% | -280.76% | -93.55% | -34.95% | -25.32% | |||
| Gross Profit (QoQ) | 47.40% | ||||||||||
| Gross Margin (QoQ) | 0.00M | ||||||||||
| Free Cash Flow (QoQ)FCF (QoQ) | 59.56% | -64.91% | 60.36% | -8,575.94% | 71.24% | 22.09% | -39.39% | -105.12% | 39.52% | -60.25% | |
| Free Cash Flow Growth (1y)FCF Growth (1y) | -2,193.56% | -1,531.31% | -670.71% | -2,610.10% | 35.93% | -34.72% | -177.09% | ||||
| FCF Margin (QoQ) | -0.18M | ||||||||||
| EPS (Diluted) (QoQ) | 75.79% | -46.91% | 142.82% | -285.87% | -178.97% | 12.98% | -47.02% | 1.01% | -10.63% | 21.35% | 7.01% |
| EPS (Diluted) Growth (1y) | 71.69% | -226.18% | -93.20% | -763.38% | -253.31% | -40.11% | -26.64% | 19.90% | |||
| EPS (Basic) (QoQ) | 75.79% | -46.91% | 147.57% | -267.31% | -178.97% | 12.98% | -47.02% | 1.01% | -10.63% | 21.35% | 7.01% |
| EPS (Basic) Growth (1y) | 71.69% | -226.18% | -93.20% | -697.11% | -253.31% | -40.11% | -26.64% | 19.90% | |||
| EBT (QoQ) | 58.07% | 0.31% | 3.63% | 2.02% | -146.87% | -3.06% | -47.36% | -1.56% | -25.49% | 28.14% | -36.85% |
| EBT Margin (QoQ) | -0.06M | ||||||||||
| EBT Growth (1y) | 60.53% | -132.39% | -140.24% | -267.34% | -280.76% | -93.55% | -34.95% | -25.32% | |||
| EBIT (QoQ) | 62.86% | -6.54% | 2.39% | 11.40% | -195.48% | -5.46% | -47.26% | -1.42% | -22.28% | 30.11% | -39.73% |
| EBIT Margin (QoQ) | -0.08M | ||||||||||
| EBIT Growth (1y) | 65.78% | -172.26% | -169.50% | -306.56% | -365.42% | -92.60% | -27.63% | -21.11% | |||
| Cash from Operations (QoQ)Cash from Ops. (QoQ) | 59.56% | -64.91% | 60.36% | -8,575.94% | 71.24% | 22.09% | -39.39% | -105.12% | 39.52% | -60.25% | |
| Cash from Operations Growth (1y)Cash from Ops. Growth (1y) | -2,193.56% | -1,531.31% | -670.71% | -2,610.10% | 35.93% | -34.72% | -177.09% | ||||
| Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) | -52.23% | -70.81% | 78.65% | -98.30% | 1,489,824.90% | -28.20% | -30.60% | -61.46% | 423.54% | -37.65% | -35.59% |
| Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) | -99.58% | 13,136.57% | 32,457.07% | 12,547.28% | 285,985.77% | 0.53% | -12.70% | -18.97% | |||
| Assets (QoQ) | 7,150.38% | -19.99% | -20.04% | -35.08% | 115.97% | -29.03% | -5.82% | ||||
| Assets Growth (1y) | 4,074.12% | 2,911.55% | -10.29% | -20.44% | -6.29% |
Pull Jupiter Neurosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=JUNS&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "JUNS", "statement": "Growth", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=JUNS&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();